Investigación Cardiovascular
Brigham and Women's Hospital
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Brigham and Women's Hospital (8)
2021
-
Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry
Circulation: Cardiovascular Interventions, Vol. 14, Núm. 5, pp. E010195
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
2017
-
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185
-
Evolocumab and clinical outcomes in patients with cardiovascular disease
New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722
2015
-
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20
2014
-
Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 312, Núm. 10, pp. 1006-1015
-
Erratum: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial (JAMA (2014) 312:10(1006-1015))
JAMA - Journal of the American Medical Association